AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease - PubMed (original) (raw)
. 2012 Apr 13;420(3):558-63.
doi: 10.1016/j.bbrc.2012.03.033. Epub 2012 Mar 16.
Affiliations
- PMID: 22445760
- DOI: 10.1016/j.bbrc.2012.03.033
AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease
Amparo Zuleta et al. Biochem Biophys Res Commun. 2012.
Abstract
Huntington's disease (HD) is caused by mutations that expand a polyglutamine region in the amino-terminal domain of Huntingtin (Htt), leading to the accumulation of intracellular inclusions and progressive neurodegeneration. Recent reports indicate the engagement of endoplasmic reticulum (ER) stress responses in human HD post mortem samples and animal models of the disease. Adaptation to ER stress is mediated by the activation of the unfolded protein response (UPR), an integrated signal transduction pathway that attenuates protein folding stress by controlling the expression of distinct transcription factors including X-Box binding protein 1 (XBP1). Here we targeted the expression of XBP1 on a novel viral-based model of HD. We delivered an active form of XBP1 locally into the striatum of adult mice using adeno-associated vectors (AAVs) and co-expressed this factor with a large fragment of mutant Htt as a fusion protein with RFP (Htt588(Q95)-mRFP) to directly visualize the accumulation of Htt inclusions in the brain. Using this approach, we observed a significant reduction in the accumulation of Htt588(Q95)-mRFP intracellular inclusion when XBP1 was co-expressed in the striatum. These results contrast with recent findings indicating a protective effect of XBP1 deficiency in neurodegeneration using knockout mice, and suggest a potential use of gene therapy strategies to manipulate the UPR in the context of HD.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
- Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy.
Vidal RL, Figueroa A, Court FA, Thielen P, Molina C, Wirth C, Caballero B, Kiffin R, Segura-Aguilar J, Cuervo AM, Glimcher LH, Hetz C. Vidal RL, et al. Hum Mol Genet. 2012 May 15;21(10):2245-62. doi: 10.1093/hmg/dds040. Epub 2012 Feb 14. Hum Mol Genet. 2012. PMID: 22337954 Free PMC article. - Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery.
Ceccarelli I, Fiengo P, Remelli R, Miragliotta V, Rossini L, Biotti I, Cappelli A, Petricca L, La Rosa S, Caricasole A, Pollio G, Scali C. Ceccarelli I, et al. Neurobiol Dis. 2016 Feb;86:41-51. doi: 10.1016/j.nbd.2015.11.019. Epub 2015 Nov 25. Neurobiol Dis. 2016. PMID: 26626080 - AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.
Franich NR, Fitzsimons HL, Fong DM, Klugmann M, During MJ, Young D. Franich NR, et al. Mol Ther. 2008 May;16(5):947-56. doi: 10.1038/mt.2008.50. Epub 2008 Mar 25. Mol Ther. 2008. PMID: 18388917 Free PMC article. - Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.
Lee CY, Cantle JP, Yang XW. Lee CY, et al. FEBS J. 2013 Sep;280(18):4382-94. doi: 10.1111/febs.12418. Epub 2013 Jul 31. FEBS J. 2013. PMID: 23829302 Free PMC article. Review. - Viral-mediated overexpression of mutant huntingtin to model HD in various species.
Ruiz M, Déglon N. Ruiz M, et al. Neurobiol Dis. 2012 Nov;48(2):202-11. doi: 10.1016/j.nbd.2011.08.023. Epub 2011 Aug 25. Neurobiol Dis. 2012. PMID: 21889981 Review.
Cited by
- Dual roles of UPRer and UPRmt in neurodegenerative diseases.
Xu S, Liu H, Wang C, Deng Y, Xu B, Yang T, Liu W. Xu S, et al. J Mol Med (Berl). 2023 Dec;101(12):1499-1512. doi: 10.1007/s00109-023-02382-9. Epub 2023 Oct 10. J Mol Med (Berl). 2023. PMID: 37817014 Review. - Endoplasmic reticulum stress: its role in disease and novel prospects for therapy.
Schönthal AH. Schönthal AH. Scientifica (Cairo). 2012;2012:857516. doi: 10.6064/2012/857516. Epub 2012 Dec 23. Scientifica (Cairo). 2012. PMID: 24278747 Free PMC article. Review. - The unfolded protein response transcription factor XBP1s ameliorates Alzheimer's disease by improving synaptic function and proteostasis.
Duran-Aniotz C, Poblete N, Rivera-Krstulovic C, Ardiles ÁO, Díaz-Hung ML, Tamburini G, Sabusap CMP, Gerakis Y, Cabral-Miranda F, Diaz J, Fuentealba M, Arriagada D, Muñoz E, Espinoza S, Martinez G, Quiroz G, Sardi P, Medinas DB, Contreras D, Piña R, Lourenco MV, Ribeiro FC, Ferreira ST, Rozas C, Morales B, Plate L, Gonzalez-Billault C, Palacios AG, Hetz C. Duran-Aniotz C, et al. Mol Ther. 2023 Jul 5;31(7):2240-2256. doi: 10.1016/j.ymthe.2023.03.028. Epub 2023 Apr 4. Mol Ther. 2023. PMID: 37016577 Free PMC article. - Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington's disease.
Stepanova P, Srinivasan V, Lindholm D, Voutilainen MH. Stepanova P, et al. Sci Rep. 2020 Nov 5;10(1):19045. doi: 10.1038/s41598-020-75439-1. Sci Rep. 2020. PMID: 33154393 Free PMC article. - Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson's disease treatment.
Lee MH, Kang S, Um KH, Lee SW, Hwang H, Baek K, Choi JW. Lee MH, et al. J Transl Med. 2024 Jan 13;22(1):53. doi: 10.1186/s12967-023-04816-x. J Transl Med. 2024. PMID: 38218903 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials